speb/financial-data huggingface dataset:
DuPont ROE decomposition for MAKO (annual period ending 2024-12-31)
ROE: 38.585675430643704%
Net margin: 20.800208523393717%
Asset turnover: 1.2085440478293423
Equity multiplier (leverage): 1.534956012222558
EBIT margin: 37.22902819410052%
Interest burden factor: 0.856180168616354
Tax burden factor: 0.6525605642440969
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAKO (annual period ending 2025-12-31)
ROE: 30.067487669533204%
Net margin: 22.724823535750847%
Asset turnover: 0.9546993359776297
Equity multiplier (leverage): 1.3858939584529715
EBIT margin: 36.544264238374915%
Interest burden factor: 1.00807254229791
Tax burden factor: 0.6168641216908
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAM.AX (annual period ending 2022-06-30)
ROE: 76.12954091636213%
Net margin: 62.530849838983826%
Asset turnover: 1.108126906106126
Equity multiplier (leverage): 1.0986753476084317
Tax burden factor: 0.7917428941988817
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAM.AX (annual period ending 2023-06-30)
ROE: 31.254263848365753%
Net margin: 50.17870503866442%
Asset turnover: 0.5630075322090913
Equity multiplier (leverage): 1.1063068965991216
Tax burden factor: 0.764923849901873
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAM.AX (annual period ending 2024-06-30)
ROE: 31.412591087160337%
Net margin: 49.975035103444654%
Asset turnover: 0.5083429161705378
Equity multiplier (leverage): 1.2364993064397825
Tax burden factor: 0.7478344733134257
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAM.AX (annual period ending 2025-06-30)
ROE: 39.229143781031375%
Net margin: 59.68759722839291%
Asset turnover: 0.5017887783045781
Equity multiplier (leverage): 1.3097963869890734
Tax burden factor: 0.7950379255191229
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAMATA.NS (quarterly period ending 2024-12-31)
Net margin: 11.943369454800958%
EBIT margin: 16.084855945335754%
Interest burden factor: 1.073491191385251
Tax burden factor: 0.691689536607678
ROE archetype: Standard Business
DuPont ROE decomposition for MAMATA.NS (quarterly period ending 2025-03-31)
ROE: 15.843342134183857%
Net margin: 24.420337688699256%
Asset turnover: 0.42850009473508327
Equity multiplier (leverage): 1.5140639305155421
EBIT margin: 32.25270187882003%
Interest burden factor: 1.0329113429235168
Tax burden factor: 0.7330312950252885
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAMATA.NS (quarterly period ending 2025-06-30)
Net margin: 6.844439846366729%
EBIT margin: 5.900138373401271%
Interest burden factor: 1.601788532351394
Tax burden factor: 0.7242200328407224
ROE archetype: Standard Business
DuPont ROE decomposition for MAMATA.NS (quarterly period ending 2025-09-30)
ROE: 2.5644494610484228%
Net margin: 8.488349434522249%
Asset turnover: 0.19597553004766208
Equity multiplier (leverage): 1.5415905779422137
EBIT margin: 10.517736290256094%
Interest burden factor: 1.127409413189867
Tax burden factor: 0.7158455266567646
ROE archetype: Low Return
DuPont ROE decomposition for MAMATA.NS (quarterly period ending 2025-12-31)
Net margin: 11.702972830631076%
EBIT margin: 10.744115187888491%
Interest burden factor: 1.3239541936109227
Tax burden factor: 0.8227209973643476
ROE archetype: Standard Business
DuPont ROE decomposition for MAMATA.NS (quarterly period ending 2026-03-31)
ROE: 0.00470092397471227%
Net margin: 0.01179629027009437%
Asset turnover: 0.2755941555444864
Equity multiplier (leverage): 1.4459982709245152
EBIT margin: 3.413059984813971%
Interest burden factor: 0.02113459399332592
Tax burden factor: 0.16353383458646614
ROE archetype: Low Return
DuPont ROE decomposition for MAMK (annual period ending 2022-10-31)
ROE: 70.48263086551654%
Net margin: 9.06530020249757%
Asset turnover: 1.9570347901921747
Equity multiplier (leverage): 3.972842696350038
EBIT margin: 11.148885123560303%
Interest burden factor: 0.9914259934983928
Tax burden factor: 0.8201446359974789
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MAMK (annual period ending 2023-10-31)
ROE: 42.94407455746973%
Net margin: 7.533346575137771%
Asset turnover: 1.9254069892602075
Equity multiplier (leverage): 2.960688769742318
EBIT margin: 9.173051851565264%
Interest burden factor: 0.9488764016957342
Tax burden factor: 0.8654947810709809
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MAMK (annual period ending 2024-10-31)
ROE: 27.505925287431104%
Net margin: 8.774177595513692%
Asset turnover: 1.424497573624035
Equity multiplier (leverage): 2.2006862227804986
EBIT margin: 10.283538846977478%
Interest burden factor: 0.9752674912802198
Tax burden factor: 0.8748630603130063
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MAMK (annual period ending 2025-10-31)
ROE: 0.1735983718039919%
Net margin: 0.062017369380749615%
Asset turnover: 1.478894778316447
Equity multiplier (leverage): 1.8927577426195783
EBIT margin: 0.3544490121880797%
Interest burden factor: 0.8260453979318935
Tax burden factor: 0.2118144840806022
ROE archetype: Low Return
DuPont ROE decomposition for MANAPPURAM.NS (annual period ending 2023-03-31)
ROE: 15.521335509519954%
Net margin: 33.64810894636523%
Asset turnover: 0.1128594345523147
Equity multiplier (leverage): 4.087243907927648
Tax burden factor: 0.7350001224859753
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MANAPPURAM.NS (annual period ending 2024-03-31)
ROE: 20.543021273807618%
Net margin: 37.005950269929464%
Asset turnover: 0.13671072637687134
Equity multiplier (leverage): 4.06059956917895
Tax burden factor: 0.7425177824624761
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MANAPPURAM.NS (annual period ending 2025-03-31)
ROE: 9.999430584851627%
Net margin: 19.274797333996457%
Asset turnover: 0.12988178758207886
Equity multiplier (leverage): 3.994267920216792
Tax burden factor: 0.7301419101829878
ROE archetype: Standard Business
DuPont ROE decomposition for MANAPPURAM.NS (annual period ending 2026-03-31)
ROE: 6.736030260567122%
Net margin: 18.19649041607482%
Asset turnover: 0.08559333913040998
Equity multiplier (leverage): 4.3249035555800734
Tax burden factor: 0.7898821932647676
ROE archetype: Standard Business
DuPont ROE decomposition for MANGLMCEM.NS (annual period ending 2023-03-31)
ROE: 2.2642800857472283%
Net margin: 0.9554309298709346%
Asset turnover: 0.9005090744281737
Equity multiplier (leverage): 2.6317386399535483
EBIT margin: 4.60958736409535%
Interest burden factor: 0.3355533524831168
Tax burden factor: 0.6176972442975828
ROE archetype: Low Return
DuPont ROE decomposition for MANGLMCEM.NS (annual period ending 2024-03-31)
ROE: 7.560393615535613%
Net margin: 3.462675974056285%
Asset turnover: 0.8434487492431891
Equity multiplier (leverage): 2.588653094763514
EBIT margin: 7.556172388689533%
Interest burden factor: 0.7605619427804918
Tax burden factor: 0.6025254640023004
ROE archetype: Standard Business
DuPont ROE decomposition for MANGLMCEM.NS (annual period ending 2025-03-31)
ROE: 5.350558931461985%
Net margin: 2.680751163095889%
Asset turnover: 0.7841445312761346
Equity multiplier (leverage): 2.545344267964316
EBIT margin: 4.687202369939865%
Interest burden factor: 0.8882833510806396
Tax burden factor: 0.6438597493891898
ROE archetype: Standard Business
DuPont ROE decomposition for MANGLMCEM.NS (annual period ending 2026-03-31)
ROE: 13.453252574220652%
Net margin: 7.3333628676561124%
Asset turnover: 0.7304276093339882
Equity multiplier (leverage): 2.511579559846634
EBIT margin: 7.735186996905891%
Interest burden factor: 0.6924883837195625
Tax burden factor: 1.369051752053042
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (quarterly period ending 2025-03-31)
Net margin: 10.61791473734632%
Asset turnover: 0.235000562830663
EBIT margin: 15.152482835701742%
Interest burden factor: 0.8050579557428873
Tax burden factor: 0.8704188481675392
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (quarterly period ending 2025-06-30)
Net margin: 11.313760379596678%
Asset turnover: 0.249810160576371
EBIT margin: 18.44602609727165%
Interest burden factor: 0.8472668810289389
Tax burden factor: 0.7239089184060721
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (quarterly period ending 2025-09-30)
Net margin: 11.21898597626753%
Asset turnover: 0.23521522428636157
EBIT margin: 17.568192325473877%
Interest burden factor: 0.8719298245614036
Tax burden factor: 0.7323943661971831
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (quarterly period ending 2025-12-31)
Net margin: 6.651718983557549%
Asset turnover: 0.24163400935473967
EBIT margin: 12.047832585949179%
Interest burden factor: 0.7220843672456576
Tax burden factor: 0.7646048109965635
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (quarterly period ending 2026-03-31)
Net margin: 9.738503155996394%
Asset turnover: 0.24022961532212936
EBIT margin: 16.05049594229035%
Interest burden factor: 0.8033707865168539
Tax burden factor: 0.7552447552447552
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (annual period ending 2022-12-31)
ROE: 415.14084507042253%
Net margin: 11.351273287440428%
Asset turnover: 0.8371146483981463
Equity multiplier (leverage): 43.688380281690144
EBIT margin: 16.72363163722139%
Interest burden factor: 0.8963730569948186
Tax burden factor: 0.7572254335260116
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MAR (annual period ending 2023-12-31)
Net margin: 13.001307299793364%
Asset turnover: 0.9393333201291371
EBIT margin: 16.547885126302027%
Interest burden factor: 0.8608562691131498
Tax burden factor: 0.9126702190645353
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (annual period ending 2024-12-31)
Net margin: 9.46215139442231%
Asset turnover: 0.9680654119099044
EBIT margin: 15.314741035856574%
Interest burden factor: 0.8197190426638917
Tax burden factor: 0.7537289749285941
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (annual period ending 2025-12-31)
Net margin: 9.93278851294585%
Asset turnover: 0.9748706302818212
EBIT margin: 15.806155961200641%
Interest burden factor: 0.8200048320850447
Tax burden factor: 0.7663523865645256
ROE archetype: Standard Business
DuPont ROE decomposition for MARA (annual period ending 2022-12-31)
ROE: -179.82593194296535%
Net margin: -589.387956145491%
Asset turnover: 0.09851795951286933
Equity multiplier (leverage): 3.0969604162294235
EBIT margin: -98.97072686046215%
ROE archetype: Low Return
DuPont ROE decomposition for MARA (annual period ending 2023-12-31)
ROE: 26.093007410101194%
Net margin: 67.39809242647894%
Asset turnover: 0.2432401810673912
Equity multiplier (leverage): 1.5916266955464462
EBIT margin: -28.53437864508604%
Tax burden factor: 0.9408283171048887
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MARA (annual period ending 2024-12-31)
ROE: 18.820093594023362%
Net margin: 82.46056388239703%
Asset turnover: 0.149307632027606
Equity multiplier (leverage): 1.5285986470818238
EBIT margin: -71.23928589928364%
Tax burden factor: 0.8779405777425252
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MARA (annual period ending 2025-12-31)
ROE: -34.453552802615306%
Net margin: -144.5805446630059%
Asset turnover: 0.12877329535549425
Equity multiplier (leverage): 1.8505394434175504
EBIT margin: -90.63778465934584%
ROE archetype: Low Return
DuPont ROE decomposition for MARINE.NS (quarterly period ending 2024-09-30)
ROE: 3.2809133279682143%
Net margin: 6.933386347020207%
Asset turnover: 0.25539195143175686
Equity multiplier (leverage): 1.8528580567902382
EBIT margin: 9.631272426256114%
Interest burden factor: 0.916228181484928
Tax burden factor: 0.7857024147333822
ROE archetype: Low Return
DuPont ROE decomposition for MARINE.NS (quarterly period ending 2024-12-31)
Net margin: 2.680505997301279%
EBIT margin: 3.7911613014750087%
Interest burden factor: 1.0911107784023628
Tax burden factor: 0.6480009979417451
ROE archetype: Standard Business
DuPont ROE decomposition for MARINE.NS (quarterly period ending 2025-03-31)
ROE: 3.3108992958077827%
Net margin: 5.388357529654153%
Asset turnover: 0.3460094609363788
Equity multiplier (leverage): 1.7758308370320417
EBIT margin: 7.2088046371429275%
Interest burden factor: 1.020879205992675
Tax burden factor: 0.7321815659412122
ROE archetype: Low Return
DuPont ROE decomposition for MARINE.NS (quarterly period ending 2025-09-30)
ROE: 3.858060218134676%
Net margin: 7.476873526684254%
Asset turnover: 0.29429178797338107
Equity multiplier (leverage): 1.7533589072007636
EBIT margin: 10.015374903316292%
Interest burden factor: 1.0027944129711077
Tax burden factor: 0.7444592287945379
ROE archetype: Low Return
DuPont ROE decomposition for MARINE.NS (quarterly period ending 2025-12-31)
Net margin: 5.6278361794225376%
EBIT margin: 7.772106740236884%
Interest burden factor: 0.9532599315760161
Tax burden factor: 0.7596111867279591
ROE archetype: Standard Business
DuPont ROE decomposition for MARINE.NS (quarterly period ending 2026-03-31)
ROE: 3.7023799746924864%
Net margin: 6.6936666454040035%
Asset turnover: 0.3116212753326903
Equity multiplier (leverage): 1.7749650566548636
EBIT margin: 9.96631489572105%
Interest burden factor: 0.8094139513355777
Tax burden factor: 0.8297720256789418
ROE archetype: Low Return
DuPont ROE decomposition for MATD.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0848673946957879
ROE archetype: Standard Business
DuPont ROE decomposition for MATD.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.1180803342823786
ROE archetype: Standard Business
DuPont ROE decomposition for MAX.V (quarterly period ending 2024-12-31)
ROE: -4.8435354846511265%
Asset turnover: 0
Equity multiplier (leverage): 1.253439550917812
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (quarterly period ending 2025-03-31)
ROE: -5.141685928650182%
Asset turnover: 0
Equity multiplier (leverage): 1.2712814466355429
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (quarterly period ending 2025-06-30)
ROE: -4.312707367785762%
Asset turnover: 0
Equity multiplier (leverage): 1.280625060241984
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (quarterly period ending 2025-09-30)
ROE: -4.1742577431255405%
Asset turnover: 0
Equity multiplier (leverage): 1.2241481469196156
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (quarterly period ending 2025-12-31)
ROE: -6.952944346538241%
Asset turnover: 0
Equity multiplier (leverage): 1.1435723153942787
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (quarterly period ending 2026-03-31)
ROE: -5.045678639645636%
Asset turnover: 0
Equity multiplier (leverage): 1.1245742676732666
ROE archetype: Low Return
DuPont ROE decomposition for MAXHEALTH.NS (annual period ending 2023-03-31)
ROE: 14.892996778499217%
Net margin: 24.582808897403623%
Asset turnover: 0.44436910070927604
Equity multiplier (leverage): 1.3633480395001614
EBIT margin: 23.28473250982969%
Interest burden factor: 1.017680150013394
Tax burden factor: 1.0374064603467077
ROE archetype: Standard Business
DuPont ROE decomposition for MAXHEALTH.NS (annual period ending 2024-03-31)
ROE: 13.275132545763057%
Net margin: 19.91984149106881%
Asset turnover: 0.4770311750710385
Equity multiplier (leverage): 1.3970315868840328
EBIT margin: 24.193894694019%
Interest burden factor: 1.062861502292596
Tax burden factor: 0.7746462367796562
ROE archetype: Standard Business
DuPont ROE decomposition for MAXHEALTH.NS (annual period ending 2025-03-31)
ROE: 11.950376458407405%
Net margin: 15.569087572861617%
Asset turnover: 0.5021369123704686
Equity multiplier (leverage): 1.5286085250348997
EBIT margin: 22.809954908282638%
Interest burden factor: 0.8922252180808882
Tax burden factor: 0.7650049418005219
ROE archetype: Standard Business
DuPont ROE decomposition for MAXHEALTH.NS (annual period ending 2026-03-31)
ROE: 13.67553001320328%
Net margin: 17.535982921257613%
Asset turnover: 0.48364711702554575
Equity multiplier (leverage): 1.6124470045917374
EBIT margin: 22.823609221645555%
Interest burden factor: 0.8925287907358284
Tax burden factor: 0.8608422158297425
ROE archetype: Standard Business
DuPont ROE decomposition for MBC (annual period ending 2022-12-31)
ROE: 15.39833531510107%
Net margin: 4.744313845214472%
Asset turnover: 1.2949711394006485
Equity multiplier (leverage): 2.506341656757828
EBIT margin: 8.389558845977714%
Interest burden factor: 0.7765647743813683
Tax burden factor: 0.7282099343955014
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBC (annual period ending 2023-12-31)
ROE: 16.5229232864276%
Net margin: 6.675959210622845%
Asset turnover: 1.1102197063794261
Equity multiplier (leverage): 2.2292782569223784
EBIT margin: 11.60589832000587%
Interest burden factor: 0.754424778761062
Tax burden factor: 0.7624633431085044
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MBC (annual period ending 2024-12-31)
ROE: 10.118545308418726%
Net margin: 4.66227225596208%
Asset turnover: 1.0168125764849854
Equity multiplier (leverage): 2.134418324291742
EBIT margin: 9.394904458598727%
Interest burden factor: 0.6633819471817107
Tax burden factor: 0.7480689245395128
ROE archetype: Standard Business
DuPont ROE decomposition for MBC (annual period ending 2025-12-31)
ROE: 2.0232637441745918%
Net margin: 0.976341097743811%
Asset turnover: 0.9070014261550198
Equity multiplier (leverage): 2.2847724775508658
EBIT margin: 4.907302446337806%
Interest burden factor: 0.3450074515648286
Tax burden factor: 0.5766738660907127
ROE archetype: Low Return
DuPont ROE decomposition for MBINN (quarterly period ending 2025-03-31)
ROE: 2.695332838131469%
Net margin: 40.139636503987155%
Asset turnover: 0.007718509612827033
Equity multiplier (leverage): 8.699724862141817
Tax burden factor: 0.7613140212816021
ROE archetype: Low Return
DuPont ROE decomposition for MBINN (quarterly period ending 2025-06-30)
ROE: 1.748114716202337%
Net margin: 21.330809796862802%
Asset turnover: 0.009386487847704173
Equity multiplier (leverage): 8.730909034841016
Tax burden factor: 0.7777413740145388
ROE archetype: Low Return
DuPont ROE decomposition for MBINN (quarterly period ending 2025-09-30)
ROE: 2.4807338484276653%
Net margin: 32.21325135887968%
Asset turnover: 0.008822197488243604
Equity multiplier (leverage): 8.729087274430814
Tax burden factor: 0.8469875973553412
ROE archetype: Low Return
DuPont ROE decomposition for MBINN (quarterly period ending 2025-12-31)
ROE: 3.011366801200037%
Net margin: 36.81782909980845%
Asset turnover: 0.009498244878888782
Equity multiplier (leverage): 8.611169117700907
Tax burden factor: 0.9183179037409994
ROE archetype: Low Return
DuPont ROE decomposition for MBINN (quarterly period ending 2026-03-31)
ROE: 2.9378047833666083%
Net margin: 38.91257138261079%
Asset turnover: 0.008753272664755294
Equity multiplier (leverage): 8.625068368198042
Tax burden factor: 0.8034066377244798
ROE archetype: Low Return
DuPont ROE decomposition for MBUU (quarterly period ending 2025-03-31)
ROE: 2.543364431126626%
Net margin: 5.760904741496182%
Asset turnover: 0.30136036670066924
Equity multiplier (leverage): 1.4649802292175096
EBIT margin: 7.595052960264495%
Interest burden factor: 0.9701733172108021
Tax burden factor: 0.7818268146477536
ROE archetype: Low Return
DuPont ROE decomposition for MBUU (quarterly period ending 2025-06-30)
ROE: 0.9237123097722132%
Net margin: 2.315022773487121%
Asset turnover: 0.2772823944114685
Equity multiplier (leverage): 1.4389946124811976
EBIT margin: 3.2984123764121733%
Interest burden factor: 0.9973641821642993
Tax burden factor: 0.7037145793569226
ROE archetype: Low Return
DuPont ROE decomposition for MBUU (quarterly period ending 2025-09-30)
ROE: -0.13494031486073468%
Net margin: -0.36049359892776267%
Asset turnover: 0.26135289949214596
Equity multiplier (leverage): 1.4322434307902274
EBIT margin: -0.4323869092552367%
ROE archetype: Low Return
DuPont ROE decomposition for MBUU (quarterly period ending 2025-12-31)
ROE: -0.4827947975036646%
Net margin: -1.3052560146748524%
Asset turnover: 0.2563985104521861
Equity multiplier (leverage): 1.442618112648851
EBIT margin: -1.8534423344042583%
ROE archetype: Low Return
DuPont ROE decomposition for MBUU (quarterly period ending 2026-03-31)
ROE: -0.473128180513584%
Net margin: -1.0246162462133748%
Asset turnover: 0.2736687129101437
Equity multiplier (leverage): 1.6873004755770842
EBIT margin: -0.8086619317940755%
ROE archetype: Low Return
DuPont ROE decomposition for MBVI (quarterly period ending 2025-09-30)
ROE: 0.6470866398046182%
Asset turnover: 0
Equity multiplier (leverage): 1.0530530907114655
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MBVI (quarterly period ending 2026-03-31)
ROE: 0.8665536839437495%
Asset turnover: 0
Equity multiplier (leverage): 1.0509807374039948
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MBX (annual period ending 2022-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MBX (annual period ending 2023-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MBX (annual period ending 2024-12-31)
ROE: -66.95211218874005%
Asset turnover: 0
Equity multiplier (leverage): 1.9068355552672267
ROE archetype: Low Return
DuPont ROE decomposition for MBX (annual period ending 2025-12-31)
ROE: -27.756775948872203%
Asset turnover: 0
Equity multiplier (leverage): 1.0431075614562804
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (annual period ending 2022-09-30)
ROE: 7.172355525989673%
Net margin: 9.376527587379504%
Asset turnover: 0.5755356221154945
Equity multiplier (leverage): 1.3290691097815819
EBIT margin: 13.683057369635874%
Interest burden factor: 0.7148546881039977
Tax burden factor: 0.9586081526408109
ROE archetype: Standard Business
DuPont ROE decomposition for MBX.TO (annual period ending 2023-09-30)
ROE: -0.1605030207066635%
Net margin: -0.23907681218322308%
Asset turnover: 0.4834936248809863
Equity multiplier (leverage): 1.3885291512750007
EBIT margin: -16.569598037539233%
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (annual period ending 2024-09-30)
ROE: 13.303294107932414%
Net margin: 13.862166196715872%
Asset turnover: 0.6886568126003232
Equity multiplier (leverage): 1.3935586231148287
EBIT margin: 15.345169288609329%
Interest burden factor: 0.9419948547196078
Tax burden factor: 0.9589829522205593
ROE archetype: Standard Business
DuPont ROE decomposition for MBX.TO (annual period ending 2025-09-30)
ROE: -7.890644319513612%
Net margin: -12.08376525918295%
Asset turnover: 0.4850328548586898
Equity multiplier (leverage): 1.3462912707595625
EBIT margin: -8.48061856839408%
ROE archetype: Low Return
DuPont ROE decomposition for MCA.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.6156066177922412
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (annual period ending 2023-03-31)
Net margin: 1.3450856669955296%
Asset turnover: 4.440163671373556
EBIT margin: 1.655879238628027%
Interest burden factor: 1.0104757747708424
Tax burden factor: 0.8038876889848812
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (annual period ending 2024-03-31)
Net margin: 1.0228159157924719%
Asset turnover: 4.761773386866826
EBIT margin: 1.3500522736615193%
Interest burden factor: 0.9084152481419324
Tax burden factor: 0.8339931380311428
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (annual period ending 2025-03-31)
Net margin: 0.9695001545741412%
Asset turnover: 5.03637881093819
EBIT margin: 1.3413136295400931%
Interest burden factor: 0.905107973421927
Tax burden factor: 0.7985776554255564
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (annual period ending 2026-03-31)
Net margin: 1.2639119549859952%
Asset turnover: 5.124124397477503
EBIT margin: 1.5997818704607987%
Interest burden factor: 0.9607995041834522
Tax burden factor: 0.8222867279471053
ROE archetype: Standard Business
DuPont ROE decomposition for MDXH (annual period ending 2022-12-31)
ROE: -472.82877079978516%
Net margin: -118.86436012306365%
Asset turnover: 0.31102530742435053
Equity multiplier (leverage): 12.789586688137408
EBIT margin: -103.6730177578669%
ROE archetype: Low Return
DuPont ROE decomposition for MDXH (annual period ending 2023-12-31)
ROE: -534.5200415330276%
Net margin: -61.40213411593748%
Asset turnover: 0.5772511764585974
Equity multiplier (leverage): 15.08049860742976
EBIT margin: -38.093542091091706%
ROE archetype: Low Return
DuPont ROE decomposition for MDXH (annual period ending 2024-12-31)
ROE: -337.9475236948242%
Net margin: -42.27587202523071%
Asset turnover: 0.6103572781762147
Equity multiplier (leverage): 13.097022278905019
EBIT margin: -26.682139723928085%
ROE archetype: Low Return
DuPont ROE decomposition for MDXH (annual period ending 2025-12-31)
ROE: -6406.115806133787%
Net margin: -31.0720741599073%
Asset turnover: 0.7510755643592016
Equity multiplier (leverage): 274.4990891987963
EBIT margin: -14.247972190034764%
ROE archetype: Low Return
DuPont ROE decomposition for MED.SW (annual period ending 2022-12-31)
ROE: -2.4320903023395672%
Net margin: -3.163151446199623%
Asset turnover: 0.5575704343476855
Equity multiplier (leverage): 1.3789863696962306
EBIT margin: -1.0228416400472584%
ROE archetype: Low Return
DuPont ROE decomposition for MED.SW (annual period ending 2023-12-31)
ROE: 0.2622539285590605%
Net margin: 0.29197286869239547%
Asset turnover: 0.6534163757911529
Equity multiplier (leverage): 1.374641627436952
EBIT margin: 3.9244172334745238%
Interest burden factor: 0.215625
Tax burden factor: 0.3450390189520624
ROE archetype: Low Return
DuPont ROE decomposition for MED.SW (annual period ending 2024-12-31)
ROE: 1.2998871362572109%
Net margin: 1.5691786275024353%
Asset turnover: 0.5388647463411828
Equity multiplier (leverage): 1.5372818141994617
EBIT margin: 3.2144143823583047%
Interest burden factor: 0.3457866334578663
Tax burden factor: 1.411764705882353
ROE archetype: Low Return
DuPont ROE decomposition for MED.SW (annual period ending 2025-12-31)
ROE: 3.6428815859281336%
Net margin: 3.467319326888437%
Asset turnover: 0.5588183608976646
Equity multiplier (leverage): 1.8800982577389012
EBIT margin: 0.7182728768425705%
Interest burden factor: 6.612202688728026
Tax burden factor: 0.7300594307162965
ROE archetype: Low Return
DuPont ROE decomposition for MEDP (quarterly period ending 2025-03-31)
ROE: 19.304794907085306%
Net margin: 20.515781370284834%
Asset turnover: 0.29439186578888976
Equity multiplier (leverage): 3.1963278858642643
EBIT margin: 20.323862720876523%
Interest burden factor: 1.0409344361935466
Tax burden factor: 0.9697469746974697
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (quarterly period ending 2025-06-30)
ROE: 23.567810329521123%
Net margin: 14.960774791111053%
Asset turnover: 0.34782571095997106
Equity multiplier (leverage): 4.529011958849026
EBIT margin: 20.94027789978966%
Interest burden factor: 0.9857759132465271
Tax burden factor: 0.7247587081854534
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (quarterly period ending 2025-09-30)
ROE: 47.69824374667376%
Net margin: 16.841111496689663%
Asset turnover: 0.3969717431877005
Equity multiplier (leverage): 7.134639650466102
EBIT margin: 21.489218870046052%
Interest burden factor: 1.0072492384068599
Tax burden factor: 0.7780601529026296
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (quarterly period ending 2025-12-31)
ROE: 35.90563190171008%
Net margin: 19.074458324511255%
Asset turnover: 0.380020405076165
Equity multiplier (leverage): 4.9534005037783375
EBIT margin: 21.634413155480274%
Interest burden factor: 1.0232532345092615
Tax burden factor: 0.861636262776329
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (quarterly period ending 2026-03-31)
ROE: 23.429498243307783%
Net margin: 17.530328161176556%
Asset turnover: 0.34425791426974106
Equity multiplier (leverage): 3.882299257129617
EBIT margin: 20.025785305489354%
Interest burden factor: 1.0430238228164774
Tax burden factor: 0.8392788178140943
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (quarterly period ending 2026-06-30)
ROE: 23.515779785404607%
Net margin: 17.157738032123575%
Asset turnover: 0.33788669803195476
Equity multiplier (leverage): 4.056283091530021
EBIT margin: 20.757467154698436%
Interest burden factor: 1.0329578270582467
Tax burden factor: 0.8002083566855462
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.9289123980847016
ROE archetype: Standard Business
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2024-12-31)
Net margin: 2.9386863202441837%
EBIT margin: 4.486546444769783%
Interest burden factor: 0.8079366212261795
Tax burden factor: 0.8107067137809186
ROE archetype: Standard Business
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2025-03-31)
ROE: 2.9504586185749866%
Net margin: 3.400549413788603%
Asset turnover: 0.4492756901218567
Equity multiplier (leverage): 1.9312011789190064
EBIT margin: 4.780376905543091%
Interest burden factor: 0.8468925379339015
Tax burden factor: 0.839960075921199
ROE archetype: Low Return
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2025-06-30)
Net margin: 2.745823053297153%
EBIT margin: 4.220832679689415%
Interest burden factor: 0.8103882540852685
Tax burden factor: 0.8027517719743773
ROE archetype: Standard Business
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2025-12-31)
Net margin: 3.2006214433386964%
EBIT margin: 4.75467272902435%
Interest burden factor: 0.8534148471615721
Tax burden factor: 0.7887756355151664
ROE archetype: Standard Business
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2026-03-31)
ROE: 3.2402132221644906%
Net margin: 3.4318555448579557%
Asset turnover: 0.4740934961396313
Equity multiplier (leverage): 1.991501295923235
EBIT margin: 5.000415686674158%
Interest burden factor: 0.861788966715651
Tax burden factor: 0.7963829628338851
ROE archetype: Low Return
DuPont ROE decomposition for MEDPLUS.NS (quarterly period ending 2026-06-30)
Net margin: 1.7650563949776548%
EBIT margin: 2.9432326026814217%
Interest burden factor: 0.7569819779107393
Tax burden factor: 0.7922248489624375
ROE archetype: Standard Business
DuPont ROE decomposition for MEG.AX (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0158654565862684
ROE archetype: Standard Business
DuPont ROE decomposition for MEGL (annual period ending 2022-12-31)
ROE: -2.818291949798512%
Net margin: -34.311408601985384%
Asset turnover: 0.07770799035282352
Equity multiplier (leverage): 1.0570164711231171
EBIT margin: -38.279885110640485%
ROE archetype: Low Return
DuPont ROE decomposition for MEGL (annual period ending 2023-12-31)
ROE: -0.35712080785779743%
Net margin: -3.507910003095991%
Asset turnover: 0.09756188449849401
Equity multiplier (leverage): 1.0434857724740982
EBIT margin: -19.141243167249492%
ROE archetype: Low Return
DuPont ROE decomposition for MEGL (annual period ending 2024-12-31)
ROE: -3.5975805645716843%
Net margin: -36.99755088886855%
Asset turnover: 0.09348093745260144
Equity multiplier (leverage): 1.0401943564062912
EBIT margin: -79.98557597915557%
ROE archetype: Low Return
DuPont ROE decomposition for MEGL (annual period ending 2025-12-31)
ROE: -6.6177777257893675%
Net margin: -72.06748200190823%
Asset turnover: 0.08789525330182492
Equity multiplier (leverage): 1.0447380345946664
EBIT margin: -104.23484257090814%
ROE archetype: Low Return
DuPont ROE decomposition for MEK.AX (annual period ending 2021-06-30)
ROE: -18.182581668430814%
Equity multiplier (leverage): 1.211092093989459
ROE archetype: Low Return
DuPont ROE decomposition for MEK.AX (annual period ending 2022-06-30)
ROE: -15.500372804028553%
Equity multiplier (leverage): 1.223382096103746
ROE archetype: Low Return
DuPont ROE decomposition for MEK.AX (annual period ending 2023-06-30)
ROE: -4.5025640002172205%
Equity multiplier (leverage): 1.2086203095923163
ROE archetype: Low Return
DuPont ROE decomposition for MEK.AX (annual period ending 2024-06-30)
ROE: -11.066194353464567%
Equity multiplier (leverage): 1.2306290710125256
ROE archetype: Low Return
DuPont ROE decomposition for MEL.MC (annual period ending 2022-12-31)
ROE: 26.942469440394746%
Net margin: 7.383669540480701%
Asset turnover: 0.37411847113281127
Equity multiplier (leverage): 9.753399125266343
EBIT margin: 9.471354265911188%
Interest burden factor: 1.014433404505247
Tax burden factor: 0.7684871826039115
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEL.MC (annual period ending 2023-12-31)
ROE: 26.28378975043369%
Net margin: 6.766938801196858%
Asset turnover: 0.4472098030196218
Equity multiplier (leverage): 8.685291935238496
EBIT margin: 12.785035218684548%
Interest burden factor: 0.6074290735422141
Tax burden factor: 0.8713542329406566
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEL.MC (annual period ending 2024-12-31)
ROE: 19.399519692055083%
Net margin: 8.050586624999688%
Asset turnover: 0.43227094449907966
Equity multiplier (leverage): 5.5745190645236775
EBIT margin: 15.59222669087856%
Interest burden factor: 0.7150950490380387
Tax burden factor: 0.7220306206109864
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEL.MC (annual period ending 2025-12-31)
ROE: 18.822643161855584%
Net margin: 9.638416197290889%
Asset turnover: 0.47695702238376975
Equity multiplier (leverage): 4.094451073532622
EBIT margin: 15.203635765038396%
Interest burden factor: 0.8422663897577469
Tax burden factor: 0.7526771786727808
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MELI (quarterly period ending 2025-03-31)
ROE: 9.87210231814548%
Net margin: 8.323504633529906%
Asset turnover: 0.21439924860920456
Equity multiplier (leverage): 5.531974420463627
EBIT margin: 12.855939342881213%
Interest burden factor: 0.9252948885976408
Tax burden factor: 0.6997167138810197
ROE archetype: Standard Business
DuPont ROE decomposition for MELI (quarterly period ending 2025-06-30)
ROE: 9.916676779966743%
Net margin: 7.702503681885125%
Asset turnover: 0.22749172510617643
Equity multiplier (leverage): 5.659377184371971
EBIT margin: 12.15022091310751%
Interest burden factor: 0.8678787878787879
Tax burden factor: 0.7304469273743016
ROE archetype: Standard Business
DuPont ROE decomposition for MELI (quarterly period ending 2025-09-30)
ROE: 7.087991588566762%
Net margin: 5.682278310163315%
Asset turnover: 0.2136989786784808
Equity multiplier (leverage): 5.837114949235645
EBIT margin: 9.771899041706034%
Interest burden factor: 0.8784530386740331
Tax burden factor: 0.6619496855345912
ROE archetype: Standard Business
DuPont ROE decomposition for MELI (quarterly period ending 2025-12-31)
ROE: 8.699891558728957%
Net margin: 6.3820070784336105%
Asset turnover: 0.22265479668601604
Equity multiplier (leverage): 6.122439498216364
EBIT margin: 10.149560452106405%
Interest burden factor: 0.8818897637795277
Tax burden factor: 0.7130102040816326
ROE archetype: Standard Business
DuPont ROE decomposition for MELI (quarterly period ending 2026-03-31)
ROE: 5.83161146586708%
Net margin: 4.714527981910685%
Asset turnover: 0.19370776078507768
Equity multiplier (leverage): 6.385623998853872
EBIT margin: 6.907857546636517%
Interest burden factor: 0.9476268412438625
Tax burden factor: 0.7202072538860104
ROE archetype: Standard Business
DuPont ROE decomposition for MESH (annual period ending 2025-12-31)
Equity multiplier (leverage): 1.0445659466473334
ROE archetype: Standard Business
DuPont ROE decomposition for MET (annual period ending 2022-12-31)
ROE: 17.599999999999998%
Net margin: 7.865418564286668%
Asset turnover: 0.1016616596689349
Equity multiplier (leverage): 22.010688796680498
Tax burden factor: 0.8331238214959146
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MET (annual period ending 2023-12-31)
ROE: 5.306568617708437%
Net margin: 2.358171166131834%
Asset turnover: 0.10059408169067476
Equity multiplier (leverage): 22.370002318725362
Tax burden factor: 0.7409805735430157
ROE archetype: Standard Business
DuPont ROE decomposition for MET (annual period ending 2024-12-31)
ROE: 15.33577196493892%
Net margin: 6.33671272333205%
Asset turnover: 0.10275295760347125
Equity multiplier (leverage): 23.5530574918904
Tax burden factor: 0.7904660263251512
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MET (annual period ending 2025-12-31)
ROE: 12.019638315908448%
Net margin: 4.498109815740079%
Asset turnover: 0.10635846601664671
Equity multiplier (leverage): 25.124028680418196
Tax burden factor: 0.7301008367303153
ROE archetype: Standard Business
DuPont ROE decomposition for MEU.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0347877363424525
ROE archetype: Standard Business
DuPont ROE decomposition for MFA (quarterly period ending 2025-03-31)
ROE: 2.239768842974667%
Net margin: 55.05033624343222%
Asset turnover: 0.006493073574509184
Equity multiplier (leverage): 6.266036192262419
Tax burden factor: 1.0216355696705042
ROE archetype: Low Return
DuPont ROE decomposition for MFA (quarterly period ending 2025-06-30)
ROE: 1.8130702895290327%
Net margin: 51.09790274398694%
Asset turnover: 0.005599849927953949
Equity multiplier (leverage): 6.336291920489131
Tax burden factor: 0.9928789420142421
ROE archetype: Low Return
DuPont ROE decomposition for MFA (quarterly period ending 2025-09-30)
ROE: 2.640437935931067%
Net margin: 62.0432589993938%
Asset turnover: 0.006523006231488857
Equity multiplier (leverage): 6.524294674717961
Tax burden factor: 1.002104035164469
ROE archetype: Low Return
DuPont ROE decomposition for MFA (quarterly period ending 2025-12-31)
ROE: 2.977031167875971%
Net margin: 66.79578460668216%
Asset turnover: 0.006468439897820269
Equity multiplier (leverage): 6.890246809853979
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MFA (quarterly period ending 2026-03-31)
ROE: -0.054559790100059555%
Net margin: -2.947254919579477%
Asset turnover: 0.0025412524423409633
Equity multiplier (leverage): 7.284624674110604
ROE archetype: Low Return
DuPont ROE decomposition for MFF.AX (annual period ending 2022-06-30)
ROE: -11.985029503079437%
Asset turnover: -0.1205493283655358
Equity multiplier (leverage): 1.4081495589977375
ROE archetype: Low Return
DuPont ROE decomposition for MFF.AX (annual period ending 2023-06-30)
ROE: 20.40734035874702%
Net margin: 69.63454105656413%
Asset turnover: 0.2102980523622987
Equity multiplier (leverage): 1.3935624628995014
Tax burden factor: 0.7000212012911153
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MFF.AX (annual period ending 2024-06-30)
ROE: 23.877260308215746%
Net margin: 69.73756206302562%
Asset turnover: 0.25862760046929595
Equity multiplier (leverage): 1.3238624459683617
Tax burden factor: 0.7
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MFF.AX (annual period ending 2025-06-30)
ROE: 18.9719965950007%
Net margin: 71.06738199472554%
Asset turnover: 0.2150822191363519
Equity multiplier (leverage): 1.2411898410083873
Tax burden factor: 0.7017448953566388
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MGA (quarterly period ending 2025-03-31)
ROE: 1.2576031563373333%
Net margin: 1.5195153441255338%
Asset turnover: 0.31393028621313207
Equity multiplier (leverage): 2.636363636363636
EBIT margin: 3.058893633925911%
Interest burden factor: 0.7305194805194806
Tax burden factor: 0.68
ROE archetype: Low Return
DuPont ROE decomposition for MGA (quarterly period ending 2025-06-30)
ROE: 3.2086599991856186%
Net margin: 3.7061424136957957%
Asset turnover: 0.33272179539804664
Equity multiplier (leverage): 2.6020782084535563
EBIT margin: 4.910168375505597%
Interest burden factor: 0.9501915708812261
Tax burden factor: 0.7943548387096774
ROE archetype: Low Return
DuPont ROE decomposition for MGA (quarterly period ending 2025-09-30)
ROE: 2.5589435979012864%
Net margin: 3.1829478111259792%
Asset turnover: 0.3143331976546299
Equity multiplier (leverage): 2.5576490094828044
EBIT margin: 5.1806537946855284%
Interest burden factor: 0.8726937269372694
Tax burden factor: 0.7040169133192389
ROE archetype: Low Return
DuPont ROE decomposition for MGA (quarterly period ending 2025-12-31)
ROE: 0.02344859696416582%
Net margin: 0.02765486725663717%
Asset turnover: 0.339793641218214
Equity multiplier (leverage): 2.4953417703297087
EBIT margin: 6.803097345132744%
Interest burden factor: 0.15447154471544713
Tax burden factor: 0.02631578947368421
ROE archetype: Low Return
DuPont ROE decomposition for MGA (quarterly period ending 2026-03-31)
ROE: -0.00790562872109144%
Net margin: -0.009632983334938831%
Asset turnover: 0.3267772109752064
Equity multiplier (leverage): 2.511445994313141
EBIT margin: 4.27704460071284%
Interest burden factor: 0.19594594594594594
Tax burden factor: -0.011494252873563218
ROE archetype: Low Return
DuPont ROE decomposition for MGA.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0313131814354366
ROE archetype: Standard Business
DuPont ROE decomposition for MGAM.L (annual period ending 2022-12-31)
ROE: 22.509310986964625%
Net margin: 8.69526121751641%
Asset turnover: 1.0899735371949428
Equity multiplier (leverage): 2.3750000000000004
EBIT margin: 12.975451847855407%
Interest burden factor: 0.911988911988912
Tax burden factor: 0.7348024316109424
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MGAM.L (annual period ending 2023-12-31)
ROE: 13.944334862179995%
Net margin: 5.050686283304925%
Asset turnover: 1.1095246689687799
Equity multiplier (leverage): 2.4883441605915655
EBIT margin: 10.702431147393916%
Interest burden factor: 0.6521374685666388
Tax burden factor: 0.7236503856041131
ROE archetype: Standard Business
DuPont ROE decomposition for MGAM.L (annual period ending 2024-12-31)
ROE: 14.830778366832847%
Net margin: 5.5466465427789835%
Asset turnover: 0.996127790640208
Equity multiplier (leverage): 2.684221784820897
EBIT margin: 11.206489953777945%
Interest burden factor: 0.6750841750841751
Tax burden factor: 0.7331670822942643
ROE archetype: Standard Business
DuPont ROE decomposition for MGAM.L (annual period ending 2025-12-31)
ROE: 8.124089830430782%
Net margin: 2.889825406381698%
Asset turnover: 1.0060988305842535
Equity multiplier (leverage): 2.7942320372636207
EBIT margin: 9.371864338751756%
Interest burden factor: 0.2462526766595289
Tax burden factor: 1.2521739130434784
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.64204729629405
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (quarterly period ending 2024-12-31)
Net margin: 1.2614782351890417%
EBIT margin: 2.1072497460455093%
Interest burden factor: 0.8173544893542625
Tax burden factor: 0.7324083709099318
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (quarterly period ending 2025-03-31)
ROE: 2.5739398636666313%
Net margin: 0.9664879786140733%
Asset turnover: 0.9656513710233414
Equity multiplier (leverage): 2.7579194523642006
EBIT margin: 1.3340492779566813%
Interest burden factor: 1.0631127622133458
Tax burden factor: 0.6814676633254949
ROE archetype: Low Return
DuPont ROE decomposition for MGEL.NS (quarterly period ending 2025-06-30)
Net margin: 0.7491989923400513%
EBIT margin: 1.3901099489880306%
Interest burden factor: 0.7096198480062339
Tax burden factor: 0.7594903826852912
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (quarterly period ending 2025-12-31)
Net margin: 1.125582482851504%
EBIT margin: 1.609792430063706%
Interest burden factor: 0.8070584755927247
Tax burden factor: 0.8663680781758958
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (quarterly period ending 2026-03-31)
ROE: 5.033235303367396%
Net margin: 1.1732983043783969%
Asset turnover: 1.3216526827629795
Equity multiplier (leverage): 3.245797707759957
EBIT margin: 2.214448522822191%
Interest burden factor: 0.7223778479508335
Tax burden factor: 0.733463377948037
ROE archetype: Standard Business
DuPont ROE decomposition for MGF (annual period ending 2022-11-30)
ROE: -15.096328043664398%
Asset turnover: -0.1405746569063432
Equity multiplier (leverage): 1.0515212278940747
ROE archetype: Low Return
DuPont ROE decomposition for MGF (annual period ending 2023-11-30)
ROE: 0.4407718831408337%
Net margin: 61.22087578114576%
Asset turnover: 0.006825837027494035
Equity multiplier (leverage): 1.0547716056909557
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MGF (annual period ending 2024-11-30)
ROE: 6.044277824587049%
Net margin: 95.86519426926918%
Asset turnover: 0.06028608608011434
Equity multiplier (leverage): 1.0458427073146397
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MGF (annual period ending 2025-11-30)
ROE: 5.057786924954541%
Net margin: 95.13824221002761%
Asset turnover: 0.051794372660507626
Equity multiplier (leverage): 1.0264146193292465
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MGH.AX (annual period ending 2022-06-30)
ROE: 13.501889457419766%
Net margin: 12.073513462628434%
Asset turnover: 0.538470149293136
Equity multiplier (leverage): 2.0768218514708816
EBIT margin: 12.02311073107495%
Interest burden factor: 1.428447924312862
Tax burden factor: 0.7029952838268376
ROE archetype: Standard Business
DuPont ROE decomposition for MGH.AX (annual period ending 2023-06-30)
ROE: 11.937760495751728%
Net margin: 8.349359827091234%
Asset turnover: 0.6496564032111004
Equity multiplier (leverage): 2.2008272776884454
EBIT margin: 8.242685457572232%
Interest burden factor: 1.4500699343692842
Tax burden factor: 0.6985467920248455
ROE archetype: Standard Business
DuPont ROE decomposition for MGH.AX (annual period ending 2024-06-30)
ROE: 11.552788974824626%
Net margin: 8.446556275926948%
Asset turnover: 0.5920323754457657
Equity multiplier (leverage): 2.3102644947014306
EBIT margin: 11.156421391566852%
Interest burden factor: 1.115505172396527
Tax burden factor: 0.678708333707391
ROE archetype: Standard Business
DuPont ROE decomposition for MGH.AX (annual period ending 2025-06-30)
ROE: 9.521005715712977%
Net margin: 7.338662567852645%
Asset turnover: 0.5703556175926145
Equity multiplier (leverage): 2.2746793405267107
EBIT margin: 9.785142187315026%
Interest burden factor: 1.0673740579135262
Tax burden factor: 0.7026404296040285
ROE archetype: Standard Business
DuPont ROE decomposition for MGR.AX (annual period ending 2022-06-30)
ROE: 8.104002859185133%
Net margin: 40.34697508896797%
Asset turnover: 0.13065969195001453
Equity multiplier (leverage): 1.5372587562544675
EBIT margin: 22.153024911032027%
Interest burden factor: 1.9779116465863453
Tax burden factor: 0.9208121827411169
ROE archetype: Standard Business
DuPont ROE decomposition for MGR.AX (annual period ending 2023-06-30)
ROE: -1.4856755725439703%
Net margin: -9.151414309484192%
Asset turnover: 0.10362387271111183
Equity multiplier (leverage): 1.5666642966234336
EBIT margin: 19.966722129783694%
Interest burden factor: -0.5055555555555555
ROE archetype: Low Return
DuPont ROE decomposition for MGR.AX (annual period ending 2024-06-30)
ROE: -8.115702253108028%
Net margin: -27.288135593220336%
Asset turnover: 0.18251450036629918
Equity multiplier (leverage): 1.629501884628237
EBIT margin: 17.220338983050848%
Interest burden factor: -1.5354330708661417
ROE archetype: Low Return
DuPont ROE decomposition for MGR.AX (annual period ending 2025-06-30)
ROE: 0.7314572888105321%
Net margin: 2.7823240589198033%
Asset turnover: 0.15795705429482904
Equity multiplier (leverage): 1.6643407041997482
EBIT margin: 10.924713584288053%
Interest burden factor: 0.11235955056179775
Tax burden factor: 2.2666666666666666
ROE archetype: Low Return
DuPont ROE decomposition for MGRX (quarterly period ending 2025-03-31)
ROE: -23.89744710061563%
Net margin: -4427.379100872779%
Asset turnover: 0.005024672176524834
Equity multiplier (leverage): 1.0742294782377722
EBIT margin: -4186.754615483139%
ROE archetype: Low Return
DuPont ROE decomposition for MGRX (quarterly period ending 2025-06-30)
ROE: -27.427040405399055%
Net margin: -3221.6109785912713%
Asset turnover: 0.007893055527677799
Equity multiplier (leverage): 1.078600684726717
EBIT margin: -3133.9755753707414%
ROE archetype: Low Return